Research grant to tackle Alzheimer’s disease

The Partnership grant will support the further development of an innovative project that targets blood vessel health in the fight against Alzheimer’s disease, a brain condition that affects memory, thinking and the ability to perform everyday activities.

The project is focused on developing a novel drug therapy that aims to mend leaky blood vessels in the brain, restore healthy vessel function and enhance clearance of toxic amyloid deposits from the brain. It is being conducted in collaboration with Professor Michael Parker, University of Melbourne and Professor David Celermajer at Royal Prince Alfred Hospital.

“It’s now becoming apparent that dementia is part of a cardiovascular disease with our research linking poor blood vessel health to Alzheimer’s and deteriorating brain function,” says Professor Gamble.

“By repairing the blood-brain barrier with our special new drug and limiting blood vessel leaks, we hope to reduce cognitive decline and improve the quality of life for millions of people affected by dementia worldwide.”

Catalyst Partnership Grants support bold, collaborative research with the potential to improve the health of Australians.

Read more about Professor Gamble’s successful grant on the Heart Foundation website.